BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12008024)

  • 1. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.
    Romero J; Hillard CJ; Calero M; Rábano A
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):85-93. PubMed ID: 12008024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
    Hillard CJ
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):3-18. PubMed ID: 10785538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
    Di Marzo V
    Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
    Gubellini P; Picconi B; Bari M; Battista N; Calabresi P; Centonze D; Bernardi G; Finazzi-Agrò A; Maccarrone M
    J Neurosci; 2002 Aug; 22(16):6900-7. PubMed ID: 12177188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
    De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
    Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence and regulation of the endocannabinoid system in human dendritic cells.
    Matias I; Pochard P; Orlando P; Salzet M; Pestel J; Di Marzo V
    Eur J Biochem; 2002 Aug; 269(15):3771-8. PubMed ID: 12153574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.
    Jarrahian A; Manna S; Edgemond WS; Campbell WB; Hillard CJ
    J Neurochem; 2000 Jun; 74(6):2597-606. PubMed ID: 10820223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemistry of the endogenous ligands of cannabinoid receptors.
    Di Marzo V; Deutsch DG
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocannabinoid system is modulated in response to spinal cord injury in rats.
    Garcia-Ovejero D; Arevalo-Martin A; Petrosino S; Docagne F; Hagen C; Bisogno T; Watanabe M; Guaza C; Di Marzo V; Molina-Holgado E
    Neurobiol Dis; 2009 Jan; 33(1):57-71. PubMed ID: 18930143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A; Beltramo M; Piomelli D
    J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
    Cravatt BF; Lichtman AH
    Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.
    Tsou K; Brown S; Sañudo-Peña MC; Mackie K; Walker JM
    Neuroscience; 1998 Mar; 83(2):393-411. PubMed ID: 9460749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R; Lichtman AH
    Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-dependent formation of endogenous cannabinoids in cortical neurons.
    Stella N; Piomelli D
    Eur J Pharmacol; 2001 Aug; 425(3):189-96. PubMed ID: 11513837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain monoglyceride lipase participating in endocannabinoid inactivation.
    Dinh TP; Carpenter D; Leslie FM; Freund TF; Katona I; Sensi SL; Kathuria S; Piomelli D
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10819-24. PubMed ID: 12136125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the synthesis of endocannabinoid related ligands.
    Razdan RK; Mahadevan A
    Chem Phys Lipids; 2002 Dec; 121(1-2):21-33. PubMed ID: 12505687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.